SINTX Technologies (SINT) said Wednesday it has published a peer-reviewed study demonstrating that silicon nitride exhibits potent antiviral activity against multiple infectious virus strains, including SARS-CoV-2 and MERS-CoV.

The study showed that direct contact to alpha-phase silicon nitride reduced infectious SARS-CoV-2 titers by up to 99.97% within 10 minutes and achieved complete inactivation after 30 minutes, SINTX said.

The study also showed 97% inactivation with contact to silicon nitride when embedded in fabric used in medical devices, the company said.

Shares of SINTX, a silicon nitride manufacturer, were 24% higher in premarket trading.